OPN Gene Polymorphism and the Serum OPN Levels Confer the Susceptibility and Prognosis of Ischemic Stroke in Chinese Patients

Introduction
Stroke is a leading cause of death and adult disability worldwide [1] [2] [3] . More than 80% of stroke cases are ischemic stroke (IS) in origin. Many environmental factors, including age, obesity, hypertension, inflammation, smoking, diabetes mellitus (DM) and lipid disorders, have been established as risk factors for IS. In addition, previous studies also suggest that genetic background can determine the predisposition to IS [4, [5] [6] [7] [8] [9] [10] .
Osteopontin (OPN) is a matricellular protein participating in many physiological and pathologic processes including wound healing, bone turnover, tumor genesis, inflammation, and immune responses [11] [12] [13] [14] . OPN mediates the lateral migration of neuroblasts from the subventricular zone after focal cerebral ischemia [15] . A recent study suggests that OPN as a novel biomarker for atherothrombosis in patients with ischemic stroke [16] . OPN levels are increased in IS patients with worse prognosis, suggesting OPN may predict the long-term outcome of IS [17] .
The expression of OPN is significantly influenced by its genetic polymorphisms [18] . Several polymorphisms in the human OPN encoding gene have been identified in different populations, of which the -66 T>G (rs28357094), -156 G>GG (rs17524488), and -443 C>T (rs11730582) polymorphisms were mostly studied. These OPN gene polymorphisms have been reported to be associated with inflammatory disease e.g. systemic lupus erythematosus [19] , chronic hepatitis C [20] , lupus nephritis [21] and large artery atherosclerosis [22] . However, the association of OPN gene polymorphisms with susceptibility to IS remains largely unknown.
In the present study, we enrolled IS patients and healthy controls to investigate the role of OPN gene polymorphism in determining the susceptibility to IS. In addition, the association of OPN gene polymorphism with the clinical outcome of IS was also investigated in this study.
Materials and Methods
Recruitment
We consecutively enrolled 560 patients in our hospital from May 2009 to May 2011 and eventually 377 patients who met the enrollment criteria were included. The diagnosis of IS was made by CT or MRI scans of the brain. All patients were recruited within 24 hours after initial stroke symptom onset. All patients had clinical signs consistent with the World Health Organization definition of stroke [23] . The Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria was used to classify the stoke subtype [24] . Only patients with small vessel disease (SVD, n=253) and large vessel disease (LVD, n=124) were included in this study. Patients with recurrent stroke, hemorrhagic stroke, liver and kidney disorders, chronic inflammatory diseases and tumors of all types were excluded from this study. A control group comprising of 551 age and sex-matched healthy individuals were recruited as controls. All controls were free from arteriosclerosis in the carotid bifurcation by ultrasound screening and did not take medications. The study was approved by the institutional ethical committee of our hospital. Informed consent was obtained from all subjects before the collection of information.
Demographic and clinical covariates
The demographic data and clinical parameters such as presence of hypertension, diabetes, smoking status, the body mass index (BMI) were obtained. The serum total cholesterol (TC), triglyceride (TG), Low density lipoprotein-cholesterol (LDL-C) and high density lipoprotein-cholesterol (HDL-C), serum creatinine (sCr) and C-reaction protein (CRP) were measured.
Stroke severity and outcome evaluation Stroke severity at admission was measured using the National Institutes of Health Stroke Scale (NIHSS; scores ranging 0-42 with higher scores indicating more severe pathology) [25] . At 12 months, the physical disability was measured with the Barthel Index (BI; scores ranging 0-100) [26] . Patients with BI score equal or less than 85 were assigned to bad recovery; those with BI score greater than 85 were assigned to good recovery. Functional outcome were measured by using modified Rankin scale (mRS) [27] . Patients with mRS score (0-1) were assigned to good recovery group; those with mRS score (2-6) were assigned to bad recovery group.
OPN gene polymorphisms
DNA was extracted from peripheral whole blood using a Qiagen DNA Isolation Kit (Qiagen, Valencia, CA, USA). Three single nucleotide polymorphisms on the promoter region of OPN gene, including -66 T>G (rs28357094), -156 G>GG (rs17524488), and -443 C>T (rs11730582), were determined using TaqMan 5′ allelic discrimination assay. It was performed using commercially available kit Assays-on-Demand™ SNP genotyping products (Applied Biosystems, Foster City, CA).
Serum OPN level detection
The levels of the full length and the thrombin-cleaved OPN in serum were determined by capture enzyme-linked immunosorbent assay (ELISA) according to the protocol provided by the manufacturer (Calbiochem, San Diego, CA). The sensitivity for OPN was 3.33 ng/ml with an intra-and inter-assay coefficients of variation (CV) being <5% and <10%, respectively [28] .
Statistical Analysis
Data on quantitative characteristics are expressed as mean ± SD. Data on qualitative characteristics are expressed as percent values or absolute numbers, as indicated. Differences in demographic characteristics between patients and controls were compared by using Student's t test and χ2 test for all categorical variables. To estimate the deviation of frequency of gene alleles, we performed the Hardy-Weinberg equilibrium using χ2 tests. Genotypes and allele frequencies were compared by χ2 analysis or Fisher's exact test. Multivariate logistic regression analysis was used to determine the influence of OPN polymorphisms on stroke risk, controlling potential confounding variables including age, sex, and other conventional risk factors. A forward stepwise (Likelihood Ratio) procedure was used for multivariable analysis. To compare the OPN genotype distribution and between patients with good outcome at 1 year, logistic regression analysis were conducted with adjustment with the demographic and clinical characteristics. Data were analyzed with the SPSS 16.0 package (SPSS Inc) and results were considered statistically significant at p<0.05 using a 2-tailed test. Table 1 summarizes the demographic data and clinical parameters of IS patients and healthy controls. The age, gender, smoking status, sCr, blood glucose, TC, HDL and TG levels were similar between IS cases and controls (all p>0.05). However, the presence of smoking, hypertension and diabetes were more prevalent in IS subjects than controls (all p<0.001). In addition, the mean BMI, serum high-sensitivity CRP (hs-CRP) level and LDL-C were higher in IS cases than that in controls (all p<0.001). Table 2 describes the genotype distributions and allele frequencies of OPN gene polymorphisms in IS and control subjects. The genotype frequencies in controls did not significantly differ from those expected under Hardy-Weinberg equilibrium (p>0.05). The genotype frequencies and alleles frequencies at -443 C>T were significantly differed between IS subjects and control subjects (both p<0.001). The presence of CC was significantly higher in IS patients than in controls (27.32 % vs. 18.69%, p=0.003). Similarly, the C allele carriage in IS was significantly higher than controls (50.80% vs. 42.65%, p=0.001).
Results
Demographic data and clinical parameters
Genotype distributions of OPN gene polymorphisms between Ischemic Stroke (IS) and control groups
To determine the independent risk factors for IS, we performed a forward stepwise logistic regression analysis. With the TT genotype as reference, the presence of CC homozygote had a significantly increased risk for IS after adjustment with age, gender, BMI, smoking status, serum CRP, TC, HDL, TG, LDL levels, the presence of diabetes and hypertension (adjusted 
Receiver operator characteristic (ROC) curve analysis of serum OPN levels
In order to determine the ability of full-length OPN and thrombin-cleaved OPN levels to discriminate the IS from controls, we performed receiver operator characteristic (ROC) curves. The ROC analyses showed that the area under curve (AUC) for thrombincleaved OPN is 0.905 (95%CI: 0.815-0.995, p=0.001, Fig. 3A) . The cut-off value of thrombincleaved OPN level was 166.8 ng/ml; with a specificity of 89.3% and a sensitivity of 57.7%. The AUC for full-length OPN was 0.658 (p=0.066, Figure 3B ). So thrombin-cleaved OPN, rather than full length OPN, can discriminate IS patients from controls with a higher specificity, but lower sensitivity.
OPN gene polymorphisms and stroke severity at admission and recovery at 12 months
We firstly analyzed the association between IS severity and the OPN polymorphisms at admission. After stratification by genotypes, we found that all the three groups of IS patients had similar mean NIHSS (GG: 13.4±1.5, GC: 13.4±1.9 and CC 13.2±2.1, p=0.341) and BI scores (GG: 75.7±10.1, GC: 77.5±12.2 and CC 76.7±11.7, p=0.489) and no significant differences were noted. the mRS; while 140 patients were assigned to bad recovery group and 119 were assigned to good recovery group according to BI scores. We found that patients with the -443 CC genotype had significantly poorer outcome at 12 months and they had significantly higher occurrence for bad recovery by mRS (OR=2.18, p=0.043) and BI (OR=2.12, p=0.05).
Serum OPN levels and IS recovery at 12 months
The associations between thrombin-cleaved OPN levels and prognosis at 12 months were also investigated in this study. We found that within IS group, patients with higher OPN (equal or above the cut-off value) were associated with poorer outcome at 12 months and they had significantly lower chances of having good recovery by mRS (OR=1.92, p=0.010) and BI (OR=2.34, p=0.001).
Discussion
In this study we investigated the possible association of OPN gene polymorphisms and the serum OPN levels with susceptibility to IS and clinical outcome of IS in a Chinese cohort. We found that only the -443 C>T polymorphism was significantly associated with the IS occurrence. The -443 CC carriers had a near 2 time higher chance to develop IS compared to the -443 TT carriers. Also, the -443 CC genotype had significantly poorer functional outcome evaluated by BI and mRS at 12 months. The serum thrombin-cleaved OPN levels in IS group were significantly higher than that in control group. ROC analysis showed that the thrombincleaved OPN levels (cut-off value is 166.8 ng/ml) can discriminate IS patients from controls with a specificity of 86.3% and a sensitivity of 57.7%. The serum thrombin-cleaved OPN was 
significantly associated with the clinical outcome. These results suggest that the potential use of OPN gene -443 C>T polymorphism and the serum thrombin-cleaved OPN to predict IS risk and prognosis. OPN has recently emerged as a key factor in both vascular remodeling and the development of atherosclerosis [29] [30] [31] [32] [33] . OPN is highly expressed in atherosclerotic plaques [34] . Transgenic mice overexpressing OPN display medial thickening and neointimal formation in the carotid artery [35] . Clinically, the concentration of OPN within the endarterectomy specimens removed from symptomatic atherosclerosis patients, suggesting that OPN is involved in the atherosclerotic plaque stability [36] . In essential hypertensive patients, plasma OPN levels were positively correlated with mean intima-media thickness (IMT) and negatively with mean diastolic and systolic flow velocities, suggesting that OPN plays a role in the development of atherosclerosis [30] . Plasma OPN levels have been shown to be correlated with the angiographic severity of coronary artery disease (CAD) [12] .
In the context of IS, one previous study have shown a large increase in the expression of OPN mRNA in the ischemic tissues following transient focal ischemia in rats [37] . In IS rat model, up-regulation of OPN was observed in the ischemic brain. Blockade of OPN activity in the ischemic brain significantly decreased focal ischemia-induced lateral migration of neuroblasts, indicating that OPN plays a significant role in post-ischemic lateral migration of neuroblasts [15] . Collectively, these studies suggest that OPN may serve as a potential marker of cardiovascular and cerebrovascular diseases. In this clinical study, we found that the serum thrombin-cleaved OPN levels are closely associated with the occurrence and outcome of IS. As far as we know, this is the first study reporting the role of OPN gene polymorphism in a clinical setting.
OPN exists either as a full-length molecule or as proteolytic fragments. The thrombincleaved OPN is a unique N-terminal fragment of OPN produced by thrombin proteolysis 6 amino acids C-terminal of the Role of Arg-Gly-Asp (RGD) domain. We found that only the thrombin-cleaved OPN had the above mentioned effect and not the full-length OPN. In contrast, most of the cited studies did not specify the isotopes of OPN in their studies.
The OPN encoding gene is mapped on human chromosome 4q21-q25 and polymorphisms in the OPN gene promoter can affect its transcriptional activity [38] . A previous study explored the possible role of −443 C>T polymorphism for OPN expression in melanoma cells. The authors found that the -443 CC genotype had higher levels of OPN mRNA compared with other allelic variants and -443 C>T variants might influence the OPN mRNA levels via binding of c-Myb transcription factor [39] . The role of OPN gene polymorphism in cardiovascular conditions has been previously reported. An association of the human -66 G>T promoter variant with carotid artery intima-media thickness was reported in Caucasian adults [40] . The OPN -443 C>T was associated with increased intima-media thickness in stroke patients [41] . In this study, we found that the -443 CC represented a near 2 time higher chance for IS incidence than TT carriers. Also, the -443 CC genotype had significantly poorer outcome and they had significantly higher risk for bad recovery.
Some limitation in this study should be addressed. Firstly, this is a single center based study, which enrolled Chinese patients in north China area, especially Liaoning, Jilin and Heilongjiang provinces. The association of OPN gene polymorphism with IS need to be duplicated in other ethnic populations. Secondly, this is a primary observational study in a clinical setting. Studies exploring the effect on endothelial function, thrombus formation and the stability of carotid AS plaque are in process to better elucidate the mechanism under which the OPN polymorphisms and OPN protein affect IS susceptibility and prognosis.
